Not checkedNot checked for notices yet.
The role of ferroptosis in lung cancer
Sikai Wu, Chengchu Zhu, Daolin Tang and 3 more
Biomarker Research · 2021
doi:10.1186/s40364-021-00338-0 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Abstract Lung cancer is one of the most common cancers in the world. Although medical treatment has made impressive progress in recent years, it is still one of the leading causes of cancer-related deaths in men and women. Ferroptosis is a type of non-apoptotic cell death modality, usually characterized by iron-dependent lipid peroxidation, rather than caspase-induced protein cleavage. Excessive or lack of ferroptosis is associated with a variety of diseases, including cancer and ischaemia-reperfusion injury. Recent preclinical evidence suggests that targeting ferroptotic pathway is a potential strategy for the treatment of lung cancer. In this review, we summarize the core mechanism and regulatory network of ferroptosis in lung cancer cells, and highlight ferroptosis induction-related tumor therapies. The reviewed information may provide new insights for targeted lung cancer therapy.
Abstract licence: CC BY-NC-ND
References159
40 more references, whose wording the paper’s licence keeps private.
All 159 referencesCited by papers we hold4
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.